AssayIndex
Reports by quarter

Reports submitted in 2025-Q3 · page 17

Kestrel Bioanalytical began contributing; gradient-length normalisation introduced. Median purity for the quarter is 99.03 % area, n=816. Read the 2025-Q3 state-of-the-index report →

816 records21 pagesmedian on this page 99.16 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-0203525-Amino-1MQMKMMKM-2508-K4002Janoshik2025-Q399.011.4399.8Supplier-supplied0FAIL
AX-2025-020241RetatrutideGGPepsGGPE-2508-E1731Janoshik2025-Q397.452.83—Buyer-sourced1FAIL
AX-2025-020155IpamorelinERPERP-2502-S9437VendorInvestigate2025-Q398.693.7795.3Buyer-sourced0FAIL
AX-2025-019916IpamorelinHJHJ-2504-X6056Janoshik2025-Q399.827.43—Buyer-sourced0PASS
AX-2025-019841SemaglutideHomopeptideHOMO-2506-M5731Janoshik2025-Q397.936.0291.4Buyer-sourced1MARGINAL
AX-2025-019750SelankHomopeptideHOMO-2507-D3703Janoshik2025-Q399.748.44—Buyer-sourced0PASS
AX-2025-019594IGF-1 LR3TFCTFC-2508-H1748VendorInvestigate2025-Q397.514.9494.0Buyer-sourced0PASS
AX-2025-019014VilonASYASY-{CAT}-1626VendorInvestigate2025-Q399.658.5692.7Laboratory-retained0FAIL
AX-2025-018493MOTS-cWWBWWB-2507-K2916PeptideMeter2025-Q399.933.53—Buyer-sourced0PASS
AX-2025-020978PT-141 (Bremelanotide)WXTWXT-2507-R4042Medutest2025-Q398.654.38—Buyer-sourced0PASS
AX-2025-020709Thymosin α1SGNSGN-2504-P9129Kestrel2025-Q399.525.48—Buyer-sourced0PASS
AX-2025-020308MK-677 (Ibutamoren mesylate)GGPepsGGPE-2507-S2892Janoshik2025-Q399.694.90—Buyer-sourced0FAIL
AX-2025-019629NAD+TFCTFC-2505-C1792Janoshik2025-Q399.9312.17—Supplier-supplied0FAIL
AX-2025-019592IGF-1 LR3TFCTFC-2508-H1748PeptideMeter2025-Q397.864.86—Buyer-sourced0PASS
AX-2025-019269GHRP-6AMBAMB-2508-T5301PeptideMeter2025-Q399.505.55—Buyer-sourced0PASS
AX-2025-019198BPC-157SinoPepSNP-2506-U4547Janoshik2025-Q399.145.0792.6Buyer-sourced1MARGINAL
AX-2025-018964BPC-157ASYASY-{CAT}-1276Janoshik2025-Q399.685.8896.6Buyer-sourced0PASS
AX-2025-020114SemaglutideERPERP-2508-S8293Janoshik2025-Q399.493.39—Supplier-supplied1MARGINAL
AX-2025-019747SelankHomopeptideHOMO-2507-D3703Janoshik2025-Q399.757.89—Buyer-sourced0PASS
AX-2025-019735SemaglutideHomopeptideHOMO-2505-V3835Janoshik2025-Q398.606.41—Buyer-sourced0PASS
AX-2025-019250CJC-1295 (no DAC)AMBAMB-2507-S5238Kestrel2025-Q399.935.5888.9Buyer-sourced1MARGINAL
AX-2025-019226Enclomiphene citrateSinoPepSNP-2503-J5227Medutest2025-Q398.634.6991.6Buyer-sourced1FAIL
AX-2025-018751Melanotan IIQSCQSC-2503-D7103Janoshik2025-Q399.826.39—Buyer-sourced0PASS
AX-2025-018725SS-31 (Elamipretide)QSCQSC-2502-M6829PeptideMeter2025-Q398.205.32107.5Buyer-sourced1FAIL
AX-2025-018590CJC-1295 (no DAC)QYBQYB-2505-C4807PeptideMeter2025-Q399.105.08104.6Buyer-sourced0PASS
AX-2025-021018TesamorelinWXTWXT-2505-B3939Janoshik2025-Q396.863.7795.9Buyer-sourced1FAIL
AX-2025-020539VilonSSASSA-2508-B6436Nordanalyt2025-Q399.265.49—Buyer-sourced0FAIL
AX-2025-020529SemaglutideSSASSA-2502-U6907Medutest2025-Q398.165.98105.7Buyer-sourced0PASS
AX-2025-020243RetatrutideGGPepsGGPE-2508-E1731Medutest2025-Q398.122.8293.6Buyer-sourced0PASS
AX-2025-019973SelankHJHJ-2507-F7054Janoshik2025-Q399.598.30—Buyer-sourced0PASS
AX-2025-019930SemaglutideHJHJ-2507-Y6433Janoshik2025-Q397.963.23—Buyer-sourced0PASS
AX-2025-019847SemaglutideHomopeptideHOMO-2506-M5731VendorInvestigate2025-Q397.366.04—Buyer-sourced1MARGINAL
AX-2025-019201BPC-157SinoPepSNP-2506-U4547Medutest2025-Q398.555.12105.6Buyer-sourced1MARGINAL
AX-2025-020574TirzepatideSSASSA-2502-D7226Nordanalyt2025-Q398.056.69—Buyer-sourced1MARGINAL
AX-2025-020520Humanin (HNG)SSASSA-2508-P6927Kestrel2025-Q399.174.5897.6Buyer-sourced0PASS
AX-2025-019875SemaglutideHJHJ-2507-E6156Medutest2025-Q399.665.0496.6Buyer-sourced0PASS
AX-2025-019467BPC-157JEEPJEEP-2506-R8215Medutest2025-Q399.153.01—Buyer-sourced0PASS
AX-2025-019303IpamorelinAMBAMB-2505-J6078Janoshik2025-Q399.934.86—Buyer-sourced0PASS
AX-2025-018497MOTS-cWWBWWB-2505-G2801PeptideMeter2025-Q399.923.12—Buyer-sourced0PASS
AX-2025-020881BPC-157WXTWXT-2506-M1881Janoshik2025-Q399.803.5296.1Supplier-supplied0PASS